Molecular discrimination of responders and nonresponders to anti-TNFalpha therapy in rheumatoid arthritis by etanercept

Overview of attention for article published in Arthritis Research & Therapy, May 2008

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

patent: 4 patents

Citations

dimensions_citation: 108 Dimensions

Readers on

mendeley: 103 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 4 patents that reference this research output.

Methods for predicting response to treatment

Grant US-11639923-B2

United States of America

METHODS OF USING CELLS ASSOCIATED WITH AUTOIMMUNE DISEASE

Application EP-3152574-A4

European Patent Office

METHODS FOR PREDICTION OF ANTI-TNF ALPHA DRUG LEVELS AND AUTOANTIBODY FORMATION

Application EP-3210016-A1

European Patent Office

IN VITRO METHOD FOR THE PROGNOSIS OR PREDICTION OF THE RESPONSE IN PATIENTS WITH…

Application WO-2010149810-A3

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.